Longitudinal associations of serum fatty acid composition with type 2 diabetes risk and markers of insulin secretion and sensitivity in the Finnish Diabetes Prevention Study

European Journal of Nutrition

Volumn 55, Issue 3, 2016, Pages 967-979

  Takkunen, Markus J ^a   Schwab, Ursula S ^a,b   de Mello, Vanessa D F ^a   Eriksson, Johan G ^c,d,e   Lindström, Jaana ^c   Tuomilehto, Jaakko ^c,f,g,h   Uusitupa, Matti I J ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f DANUBE UNIVERSITY KREMS   (Austria)

^g HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^h KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Biomarkers; Cohort study; Fatty acid desaturases; Omega 3 fatty acids; Serum fatty acids; Type 2 diabetes

Indexed keywords

ACYL COENZYME A DESATURASE; ACYL COENZYME A DESATURASE 1; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; GLUCOSE; ICOSAPENTAENOIC ACID; INSULIN; LINOLENIC ACID; LINOLEOYL COENZYME A DESATURASE; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; SATURATED FATTY ACID; TRANS FATTY ACID; BIOLOGICAL MARKER; CARBOHYDRATE DIET; DELTA-5 FATTY ACID DESATURASE; FAT INTAKE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; FEMALE; FINN (CITIZEN); FOLLOW UP; GAS CHROMATOGRAPHY; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; LIPID COMPOSITION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PREVENTION STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; ADMINISTRATION AND DOSAGE; ANALYSIS; BLOOD; BODY MASS; CALORIC INTAKE; CARBOHYDRATE DIET; DIABETES MELLITUS, TYPE 2; DIETARY FIBER; EXERCISE; FAT INTAKE; FINLAND; GENETICS; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECRETION (PROCESS);

ADULT; AGED; BIOMARKERS; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY FIBER; ENERGY INTAKE; EXERCISE; FATTY ACID DESATURASES; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FEMALE; FINLAND; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OVERWEIGHT; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; STEAROYL-COA DESATURASE;

EID: 84928675177     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-015-0911-4     Document Type: Article

References (37)

1. Tuomilehto J, Lindström J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350. doi:10.1056/NEJM200105033441801
2. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403. doi:10.1056/NEJMoa012512
3. Ley SH, Hamdy O, Mohan V, Hu FB (2014) Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet 383:1999–2007
4. Rivellese AA, Lilli S (2003) Quality of dietary fatty acids, insulin sensitivity and type 2 diabetes. Biomed Pharmacother 57:84–87
5. Zhang M, Picard-Deland E, Marette A (2013) Fish and marine omega-3 polyunsaturated fatty acid consumption and incidence of type 2 diabetes: a systematic review and meta-analysis. Int J Endocrinol 2013:501015. doi:10.1155/2013/501015
6. Schwab U, Lauritzen L, Tholstrup T, Haldorssoni T, Riserus U, Uusitupa M, Becker W (2014) Effect of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type 2 diabetes, cardiovascular diseases, and cancer: a systematic review. Food Nutr Res. doi:10.3402/fnr.v58.25145 (eCollection 2014)
7. Krachler B, Norberg M, Eriksson JW, Hallmans G, Johansson I, Vessby B, Weinehall L, Lindahl B (2008) Fatty acid profile of the erythrocyte membrane preceding development of type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis 18:503–510. doi:10.1016/j.numecd.2007.04.005
8. Fumeron F, Lamri A, Abi Khalil C et al (2011) Dairy consumption and the incidence of hyperglycemia and the metabolic syndrome: results from a French prospective study, Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 34:813–817. doi:10.2337/dc10-1772
9. Sampath H, Ntambi JM (2005) Polyunsaturated fatty acid regulation of genes of lipid metabolism. Annu Rev Nutr 25:317–340. doi:10.1146/annurev.nutr.25.051804.101917
10. Gehrmann W, Elsner M, Lenzen S (2010) Role of metabolically generated reactive oxygen species for lipotoxicity in pancreatic beta-cells. Diabetes Obes Metab 12(Suppl 2):149–158. doi:10.1111/j.1463-1326.2010.01265.x
11. Hodson L, Skeaff CM, Fielding BA (2008) Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 47:348–380. doi:10.1016/j.plipres.2008.03.003
12. Sampath H, Ntambi JM (2011) The role of stearoyl-CoA desaturase in obesity, insulin resistance, and inflammation. Ann N Y Acad Sci 1243:47–53. doi:10.1111/j.1749-6632.2011.06303.x
13. Warensjo E, Ingelsson E, Lundmark P, Lannfelt L, Syvanen AC, Vessby B, Riserus U (2007) Polymorphisms in the SCD1 gene: associations with body fat distribution and insulin sensitivity. Obesity (Silver Spring) 15:1732–1740
14. Kröger J, Schulze MB (2012) Recent insights into the relation of Delta5 desaturase and Delta6 desaturase activity to the development of type 2 diabetes. Curr Opin Lipidol 23:4–10. doi:10.1097/MOL.0b013e32834d2dc5
15. Vessby B, Aro A, Skarfors E, Berglund L, Salminen I, Lithell H (1994) The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters. Diabetes 43:1353–1357
16. Wang L, Folsom AR, Zheng ZJ, Pankow JS, Eckfeldt JH, ARIC Study Investigators (2003) Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 78:91–98
17. Kröger J, Zietemann V, Enzenbach C et al (2011) Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European prospective investigation into cancer and nutrition (EPIC)–potsdam study. Am J Clin Nutr 93:127–142. doi:10.3945/ajcn.110.005447
18. Djousse L, Biggs ML, Lemaitre RN et al (2011) Plasma omega-3 fatty acids and incident diabetes in older adults. Am J Clin Nutr 94:527–533. doi:10.3945/ajcn.111.013334
19. Mahendran Y, Agren J, Uusitupa M et al (2014) Association of erythrocyte membrane fatty acids with changes in glycemia and risk of type 2 diabetes. Am J Clin Nutr 99:79–85. doi:10.3945/ajcn.113.069740
20. Virtanen JK, Mursu J, Voutilainen S, Uusitupa M, Tuomainen TP (2014) Serum omega-3 polyunsaturated fatty acids and risk of incident type 2 diabetes in men: the Kuopio ischemic heart disease risk factor study. Diabetes Care 37:189–196. doi:10.2337/dc13-1504
21. Eriksson J, Lindström J, Valle T et al (1999) Prevention of Type II diabetes in subjects with impaired glucose tolerance: the diabetes prevention study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia 42:793–801
22. Lindström J, Peltonen M, Eriksson JG et al (2013) Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). Diabetologia 56:284–293. doi:10.1007/s00125-012-2752-5
23. Lindström J, Louheranta A, Mannelin M et al (2003) The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 26:3230–3236
24. Voight BF, Kang HM, Ding J et al (2012) The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet 8:e1002793. doi:10.1371/journal.pgen.1002793
25. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497–509
26. de Mello VD, Lindström J, Eriksson J et al (2012) Insulin secretion and its determinants in the progression of impaired glucose tolerance to type 2 diabetes in impaired glucose-tolerant individuals: the Finnish Diabetes Prevention Study. Diabetes Care 35:211–217. doi:10.2337/dc11-1272
27. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470
28. Stancakova A, Javorsky M, Kuulasmaa T, Haffner SM, Kuusisto J, Laakso M (2009) Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men. Diabetes 58:1212–1221. doi:10.2337/db08-1607
29. Zhu J, Sun Q, Zong G et al (2013) Interaction between a common variant in FADS1 and erythrocyte polyunsaturated fatty acids on lipid profile in Chinese Hans. J Lipid Res 54:1477–1483. doi:10.1194/jlr.P027516
30. Dupuis J, Langenberg C, Prokopenko I et al (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42:105–116. doi:10.1038/ng.520
31. Wu JH, Micha R, Imamura F et al (2012) Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis. Br J Nutr 107(Suppl 2):S214–S227. doi:10.1017/S0007114512001602
32. Risk and Prevention Study Collaborative Group, Roncaglioni MC, Tombesi M et al (2013) N-3 fatty acids in patients with multiple cardiovascular risk factors. N Engl J Med 368:1800–1808. doi:10.1056/NEJMoa1205409
33. ORIGIN Trial Investigators, Bosch J, Gerstein HC et al (2012) N-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 367:309–318. doi:10.1056/NEJMoa1203859
34. Akinkuolie AO, Ngwa JS, Meigs JB, Djousse L (2011) Omega-3 polyunsaturated fatty acid and insulin sensitivity: a meta-analysis of randomized controlled trials. Clin Nutr 30:702–707. doi:10.1016/j.clnu.2011.08.013
35. Forouhi NG, Koulman A, Sharp SJ et al (2014) Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-interact case–cohort study. Lancet Diabetes Endocrinol 2:810–818. doi:10.1016/S2213-8587(14)70146-9
36. Peter A, Cegan A, Wagner S et al (2011) Relationships between hepatic stearoyl-CoA desaturase-1 activity and mRNA expression with liver fat content in humans. Am J Physiol Endocrinol Metab 300:E321–E326. doi:10.1152/ajpendo.00306.2010
37. Vessby B, Uusitupa M, Hermansen K et al (2001) Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU study. Diabetologia 44:312–319